Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis

被引：0
|
作者：
Evan W. Davies
Louis S. Matza
Gavin Worth
David H. Feeny
Jacqueline Kostelec
Steven Soroka
David Mendelssohn
Philip McFarlane
Vasily Belozeroff
机构：
[1] Outcomes Research,Department of Economics
[2] Evidera,Department of Medicine
[3] Outcomes Research,Department of Nephrology
[4] Evidera,Division of Nephrology
[5] Amgen (Europe) GmbH,undefined
[6] McMaster University,undefined
[7] Dalhousie University,undefined
[8] Humber River Hospital,undefined
[9] St. Michael’s Hospital,undefined
[10] Amgen,undefined
[11] Inc,undefined
来源：
Health and Quality of Life Outcomes | / 13卷
关键词：
Utility; Chronic kidney disease; Secondary hyperparathyroidism; End-stage renal disease; Standard gamble;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis
    Gan, Lingling
    Wang, Lijun
    Li, Wanyi
    Zhang, Yamei
    Xu, Bei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [32] Cost-Effectiveness and Clinical Outcomes of Secondary Hyperparathyroidism Treatments in Patients with Chronic Kidney Disease
    Zhang, Wenjie
    Ren, Hailiang
    Liao, Qianxiu
    Wu, Jian
    CALCIFIED TISSUE INTERNATIONAL, 2024, 114 (04) : 368 - 376
  • [33] Cost-Effectiveness and Clinical Outcomes of Secondary Hyperparathyroidism Treatments in Patients with Chronic Kidney Disease
    Wenjie Zhang
    Hailiang Ren
    Qianxiu Liao
    Jian Wu
    Calcified Tissue International, 2024, 114 : 368 - 376
  • [34] Clinical and nutritional factors associated with dialysis initiation and mortality in chronic kidney disease
    de Oliveira M.C.
    Tapias T.M.
    de Góes C.R.
    Martin L.C.
    Balbi A.L.
    Bufarah M.N.B.
    Vannini F.C.D.
    Nutrire, 42 (1)
  • [35] Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis
    Montenegro, Jesus
    Isabel Gallardo, Inaki Cornago
    Garcia-Ledesma, Paula
    Hernando, Ainhoa
    Martinez, Isabel
    Munoz, Rosa I.
    Romero, Marco A.
    NEPHROLOGY, 2012, 17 (01) : 26 - 31
  • [36] CLINICAL BENEFITS ON SECONDARY HYPERPARATHYROIDISM AND CHRONIC KIDNEY DISEASE PROGRESSION OF SEVELAMER TREATMENT ON PRE-DIALYSIS PATIENTS: TWO YEARS FOLLOW-UP
    Lullo, Luca D. I.
    Floccari, Fulvio
    Rivera, Rodolfo
    Granata, Antonio
    Faiola, Rossella
    Feliziani, Cherubino
    Villani, Annalisa
    Malaguti, Moreno
    Santoboni, Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 114 - 115
  • [37] Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities
    Khan, Samina
    NEPHRON CLINICAL PRACTICE, 2007, 105 (04): : C159 - C164
  • [38] Secondary hyperparathyroidism due to chronic kidney disease and access to clinical treatment and parathyroidectomy in Brazil: a nationwide survey
    Pelepenko, Lauter Eston
    Louca, Marcelo Giacomini
    Fausto, Tarcisio
    Elias Bucharles, Sergio Gardano
    Custodio, Melani Ribeiro
    Lucca, Leandro
    Barreto, Fellype de Carvalho
    Carvalho, Aluizio Barbosa
    Jorgetti, Vanda
    Moura-Neto, Jose Andrade
    de Oliveira, Rodrigo Bueno
    JORNAL BRASILEIRO DE NEFROLOGIA, 2025, 47 (02):
  • [39] Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism
    Camelo Albuquerque, Roxana de Fatima
    Moraes Carbonara, Cinthia Esbrile
    Martin, Rita de Cassia T.
    dos Reis, Luciene Machado
    do Nascimento Junior, Climerio Pereira
    Arap, Sergio Samir
    Moyses, Rosa M. A.
    Jorgetti, Vanda
    Montenegro, Fabio L. M.
    de Oliveira, Rodrigo Bueno
    SURGERY, 2018, 163 (02) : 381 - 387
  • [40] Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort
    Bozic, Milica
    Diaz-Tocados, Juan M.
    Bermudez-Lopez, Marcelino
    Forne, Carles
    Martinez, Cristina
    Fernandez, Elvira
    Valdivielso, Jose M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (04) : 663 - 672
12345